US Patent 11053485 MAD nucleases
Patent 11053485 was granted and assigned to Inscripta on July, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+137 characters)
Article
Patent abstract
The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Aamir Mir0
Andrew Garst0
Benjamin Mijts0
Juhan Kim0
Kyle Seamon0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 22 Mar, 2023
Golden AI
Infobox
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110534850
Date of Patent
July 6, 2021
0Patent Application Number
170845220
Date Filed
October 29, 2020
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 11053485 MAD nucleases
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11053485
Date of patent
July 6, 2021
Patent application number
17084522
Date Filed
October 29, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11053485 MAD nucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
